Business Segments DSM-Firmenich Euronext Amsterdam
Stocks
DSM
NL0000009827
Consumer Goods Conglomerates
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 114.05 EUR | +0.13% |
|
-.--% | - |
| 06-10 | Dsm-Firmenich Receives FDA Approval for PARSOL Shield, New Sun Protection Ingredient for the U.S | CI |
| 06-10 | DSM-Firmenich's Sunscreen Ingredient Gets US FDA's Nod | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Beauty Care Products | ||||||||||
Perfumery & Beauty | - | - | 2.62B | 3.96B | 3.76B | |||||
CAPEX | - | - | -112M | -189M | -170M | |||||
EBITDA | - | - | 579M | 882M | 815M | |||||
Operating Income | - | - | 317M | 491M | 460M | |||||
Prepared and Preserved Foods | ||||||||||
Taste, Texture & Health | - | - | 2.47B | 3.24B | 3.15B | |||||
CAPEX | - | - | -86M | -161M | -315M | |||||
EBITDA | - | - | 437M | 615M | 648M | |||||
Operating Income | - | - | 169M | 279M | 322M | |||||
Vitamins and Nutritional Supplements | ||||||||||
Health Nutrition & Care | - | 2.94B | 2.25B | 2.21B | 2.1B | |||||
CAPEX | - | - | -129M | -127M | -123M | |||||
EBITDA | - | 676M | 377M | 371M | 407M | |||||
Operating Income | - | 428M | 158M | 188M | 213M | |||||
Nutrition | 7.08B | - | - | - | - | |||||
Total Assets | 11B | - | - | - | - | |||||
CAPEX | -488M | - | - | - | - | |||||
EBITDA | 1.45B | - | - | - | - | |||||
D&A | 484M | - | - | - | - | |||||
Operating Income | 940M | - | - | - | - | |||||
Corporate Activities | 70M | 71M | 68M | 52M | 26M | |||||
Total Assets | 2.82B | - | - | - | - | |||||
CAPEX | -53M | - | -121M | - | - | |||||
EBITDA | -94M | -95M | -78M | -93M | -98M | |||||
D&A | 39M | - | - | - | - | |||||
Operating Income | -136M | -149M | -134M | -156M | -134M | |||||
Food & Beverages | - | 1.55B | - | - | - | |||||
EBITDA | - | 266M | - | - | - | |||||
Operating Income | - | 136M | - | - | - | |||||
Eliminations | -76M | - | - | - | - | |||||
Total Assets | 56M | - | - | - | - | |||||
Animal Feed | ||||||||||
Animal Nutrition & Health | - | 3.79B | 3.22B | 3.32B | - | |||||
CAPEX | - | - | -252M | -287M | - | |||||
EBITDA | - | 546M | 128M | 343M | - | |||||
Operating Income | - | 351M | -80M | 124M | - | |||||
Biological Products | ||||||||||
Innovation Center | 186M | - | - | - | - | |||||
Total Assets | 566M | - | - | - | - | |||||
CAPEX | -2M | - | - | - | - | |||||
EBITDA | 26M | - | - | - | - | |||||
D&A | 23M | - | - | - | - | |||||
Operating Income | 4M | - | - | - | - | |||||
Plastic and Synthetic Resins | ||||||||||
Materials | 1.95B | - | - | - | - | |||||
Total Assets | 1.57B | - | - | - | - | |||||
CAPEX | -65M | - | - | - | - | |||||
EBITDA | 435M | - | - | - | - | |||||
D&A | 100M | - | - | - | - | |||||
Operating Income | 331M | - | - | - | - | |||||
Information Technology (IT) Consulting | ||||||||||
Other Activities | - | 46M | - | - | - | |||||
EBITDA | - | 2M | - | - | - | |||||
Operating Income | - | 1M | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Rest of EMEA | - | - | 3.1B | 3.94B | 3.1B | |||||
Total Assets | - | - | 3.15B | 3.22B | 3.28B | |||||
North America | 1.31B | 1.87B | 2.42B | 2.93B | 2.35B | |||||
Total Assets | 3.12B | 2.14B | 2.6B | 2.69B | 2.39B | |||||
CAPEX | -87M | - | - | - | - | |||||
Rest of Asia | 387M | 1.19B | 1.83B | 2.32B | 1.54B | |||||
Total Assets | 576M | 113M | 283M | 299M | 297M | |||||
CAPEX | -5M | - | - | - | - | |||||
Latin America | 666M | 1.51B | 1.65B | 1.89B | 857M | |||||
Total Assets | 864M | 404M | 506M | 428M | 322M | |||||
CAPEX | -20M | - | - | - | - | |||||
China | 1.18B | 803M | 997M | 1.1B | 671M | |||||
Total Assets | 1.46B | 774M | 612M | 603M | 522M | |||||
CAPEX | -77M | - | - | - | - | |||||
Netherlands | 1.86B | 402M | 424M | 420M | 302M | |||||
Total Assets | 4.57B | 1.3B | 1.66B | 1.62B | 1.56B | |||||
CAPEX | -108M | - | - | - | - | |||||
Switzerland | 2.37B | 156M | 204M | 214M | 214M | |||||
Total Assets | 2.59B | 1.85B | 15.47B | 14.95B | 11.19B | |||||
CAPEX | -147M | - | - | - | - | |||||
Rest of Western Europe | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Eastern Europe | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Japan | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
India | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Rest of Europe | 1.34B | 2.15B | - | - | - | |||||
Total Assets | 2.74B | 2.1B | - | - | - | |||||
CAPEX | -162M | - | - | - | - | |||||
Rest of the World | 98M | 311M | - | - | - | |||||
Total Assets | 101M | 34M | - | - | - | |||||
CAPEX | -2M | - | - | - | - |
- Stock Market
- Stocks
- DSFIR Stock
- DSM Stock
- Financials DSM-Firmenich
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
















